Antiepileptic Drugs in Elderly Patients
ConditionSeizure, Epileptic
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65-100
SponsorWei Zhao
About this trial
The purpose is to study the population pharmacokinetics, effectiveness and safety of antiepileptic drug (phenytoin, carbamazepine, lamotrigine, levetiracetam, parempanel, etc) in elderly patients and recommend optimized dosage regimens.
Eligibility criteria
Qualifiers
Age ≥65 years old;
Diagnosed with epilepsy;
Using antiepileptic drugs for treatment;
Disqualifiers
Patients who are expected to die within 48 hours;
Patients with allergy to antiepileptic drugs;
Patients receiving other investigational drugs;
Other factors that the researcher considers unsuitable for inclusion.
Trial design
Treatments tested in this trial
- antiepileptic drugs
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Wei Zhao
Lead sponsor
Shandong University
Sponsor institution
Qianfoshan Hospital
Collaborator
The Second Hospital of Shandong University
Collaborator
The Affiliated Hospital of Qingdao University
Collaborator
Source ClinicalTrials.gov